Julian Sturdy
Main Page: Julian Sturdy (Conservative - York Outer)Department Debates - View all Julian Sturdy's debates with the Leader of the House
(9 years, 2 months ago)
Commons ChamberRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Mr Hague
I think the hon. Gentleman has made his point without a debate. Indeed, he has conducted a short debate on the issue. There will not be time for a debate in the remaining days of this Parliament, although there will be Home Office questions on Monday 23 March, so he will have a further opportunity to advertise his early-day motion and his arguments. I am sure that these issues are well understood by many hon. Members, irrespective of the number of asylum seekers living in their constituencies.
Julian Sturdy (York Outer) (Con)
While I accept the success of the cancer drugs fund, recent changes have resulted in the drug regorafenib, which is effective against gastro-intestinal tumours, no longer being funded. One of my constituents, whose partner suffers from a rare form of cancer, has collected more than 45,000 signatures in support of the drug’s reinstatement. It is a last resort that offers treatment when others have failed, and it gives patients precious extra time until a lasting cure can be found. Given that we are running out of time in this Parliament, can the Leader of the House advise me on how we can get this matter debated?
Mr Hague
There is little scope for additional debates, as I have been saying in relation to other issues, but I can tell my hon. Friend that NHS England, which manages the cancer drugs fund, has assured the Department of Health that no patient whose treatment is currently being funded through the cancer drugs fund will have their funding withdrawn as long as it is clinically appropriate that they continue to receive that treatment, and that in addition no drug will be removed from the fund when it is the only therapy available for the condition in question. Furthermore, clinicians can still apply for individual patients to receive a particular drug on an exceptional basis. I would recommend that my hon. Friend pursues the matter directly with Ministers at the Department of Health in order to get further details.